Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.

NCT02209948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide

Sponsor

Grupo Español de Investigación en Neurooncología